Sign in

CIK 0001636282

  • Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464312787
Phone
+1 617-651-5940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,349,597
in 6 filings, $12.3M under 10b5-1 plans

Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 21 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-08 Shanafelt Armen Director Grant or award · Director Stock Option (right to buy) +40,000 40,000
2021-06-08 Mahatme Sandesh Director Grant or award · Director Stock Option (right to buy) +40,000 40,000
2021-06-08 Magovcevic-Liebisch Ivana Director Grant or award · Director Stock Option (right to buy) +40,000 40,000
2021-06-08 Lawton Alison Frances Director Grant or award · Director Stock Option (right to buy) +40,000 40,000
2021-06-08 LAWLIS V BRYAN Director Grant or award · Director Stock Option (right to buy) +40,000 40,000
2021-06-08 Cox Russell J. Director Grant or award · Director Stock Option (right to buy) +40,000 40,000
2021-02-23 BAKER BROS. ADVISORS LP Director Grant or award · Non-Qualified Stock Option (right to buy) +47,200 47,200
2021-02-17 Weber Steven VP, Controller&Princ Acctg Off Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2021-02-17 Sloan Leslie Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +160,000 160,000
2021-02-17 Quinn Anthony G. President & CEO Grant or award · Employee Stock Option (right to buy) +330,000 330,000
2021-02-17 Hanley Jr. Michael Conick Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +135,000 135,000
2020-12-15 Lawton Alison Frances Director Grant or award · Director Stock Option (right to buy) +47,200 47,200
2020-06-08 Shanafelt Armen Director Grant or award · Director Stock Option (right to buy) +28,100 28,100
2020-06-08 Mahatme Sandesh Director Grant or award · Director Stock Option (right to buy) +28,100 28,100
2020-06-08 Magovcevic Ivana Director Grant or award · Director Stock Option (right to buy) +28,100 28,100
2020-06-08 LAWLIS V BRYAN Director Grant or award · Director Stock Option (right to buy) +28,100 28,100
2020-06-08 Cox Russell J. Director Grant or award · Director Stock Option (right to buy) +28,100 28,100
2020-06-08 Bruhn Suzanne Louise Director Grant or award · Director Stock Option (right to buy) +28,100 28,100
2020-04-30 Quinn Anthony G. President & CEO Purchase +165,000 $4.75 $784K 538,469
2020-02-14 York Charles N II Chief Financial Officer and VP Grant or award · Employee Stock Option (right to buy) +126,000 126,000

Page 13 of 19 · 372 trades